ZGPAT inhibitors are a class of compounds that specifically target and inhibit the activity of the ZGPAT protein, which is a zinc finger-containing transcriptional repressor. ZGPAT, also known as Zinc Finger, G Patch, and Transcriptional Regulator, is involved in the regulation of gene expression by binding to specific DNA sequences and modulating transcription. This protein contains zinc finger motifs, which enable it to interact directly with DNA, and a G patch domain that is thought to mediate interactions with other proteins involved in gene expression. The inhibition of ZGPAT disrupts its ability to regulate downstream target genes, thereby affecting cellular processes associated with transcriptional regulation, chromatin remodeling, and potentially cell growth and proliferation.
The development of ZGPAT inhibitors involves designing small molecules that can selectively bind to this protein, preventing its interaction with DNA or other associated proteins. The molecular architecture of these inhibitors often involves features that allow them to specifically target the zinc finger domain or other critical regions of ZGPAT, interfering with its function. By blocking ZGPAT's activity, these inhibitors provide valuable tools for studying transcriptional regulation and the broader role of zinc finger proteins in gene control. Furthermore, their selective targeting of ZGPAT opens up avenues for investigating the biological consequences of altered gene expression patterns, particularly in contexts where ZGPAT is abnormally expressed or dysregulated. As research into these inhibitors progresses, they continue to contribute to our understanding of transcriptional networks and the diverse roles that zinc finger proteins play in regulating cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA polymerase, potentially affecting RNA processing and indirectly influencing ZGPAT. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
RNA polymerase II inhibitor, may impact transcription processes relevant to ZGPAT. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits CRM1/exportin 1, affecting nuclear export of RNA, potentially influencing ZGPAT. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA Polymerase I, II, and III, possibly affecting ZGPAT-related RNA processing. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA Polymerase II, potentially impacting transcription processes involving ZGPAT. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Adenosine analog, inhibits RNA polyadenylation, potentially affecting ZGPAT function. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Inhibits CDK9/cyclin T (part of P-TEFb), affecting transcription elongation relevant to ZGPAT. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor, may indirectly affect proteins involved in RNA processing including ZGPAT. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, could indirectly influence ZGPAT by affecting protein turnover. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, potentially impacting proteins associated with RNA processing and ZGPAT. | ||||||